Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-04-06

Clinical Trial Update: Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating peri-articular injection of a pain cocktail with and without Exparel for pain management in total knee arthroplasty has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: University of Louisville | Conditions: Total Knee Arthroplasty, Pain Management | Phase 4 | Status: WITHDRAWN